76.8K
Downloads
55
Episodes
Written by expert consultants and clinical scientists currently practising in the UK, the BSH Guidelines provide up-to-date evidence-based guidance on the diagnosis and treatment of haematological diseases. Self accreditation Listen to two podcasts and earn one CPD point via self-accreditation Join our Guidelines Newsletter to be notified when new guidelines/good practice papers are published by going into your members account under MyBSH. Non members can email bshguidelines@b-s-h.org.uk to sign up for updates.
Episodes
Tuesday Sep 24, 2024
Diagnosis and management of smouldering myeloma
Tuesday Sep 24, 2024
Tuesday Sep 24, 2024
Professor Guy Pratt discusses the investigation, diagnosis and management of smouldering myeloma. This podcast is based on the British Society for Haematology’s 2024 Good Practice Paper, Diagnosis and management of smouldering myeloma.
Monday Jul 22, 2024
The assessment and management of bleeding risk prior to invasive procedures
Monday Jul 22, 2024
Monday Jul 22, 2024
This guidance update from the BSH is focussed primarily on non-surgical invasive procedures, simply termed ‘procedures’ in this document, with the primary objective of giving pragmatic advice where evidence is limited. This guidance also aims to reduce unnecessary laboratory testing, inappropriate use of blood products and unnecessary delays in therapeutic procedures.1 It should be read in conjunction with the Interventional Radiology (IR) procedure bleeding risk guidance produced by the British Society of Interventional Radiology (BSIR) and the BSH.2 Recommendations are predominantly based on evidence from adult patients and therefore may not be applicable to neonates or very young children.
Monday Jul 22, 2024
The management of myelofibrosis: A British Society for Haematology Guideline
Monday Jul 22, 2024
Monday Jul 22, 2024
Friday Jul 12, 2024
Friday Jul 12, 2024
Since the last version of the BCSH (British Committee for Standards in Haematology) Guidelines for Specification, implementation and management of Information Technology (IT) in hospital transfusion laboratories was published1 there has been continued development in IT applications for use in transfusion medicine. IT has made a major contribution to blood safety throughout the transfusion chain, and there is increasing use of IT solutions to allow laboratories to meet some of the challenges of the Blood Safety and Quality Regulations (F24) SI 50/2005 (as amended) legislation 2, such as traceability. These guidelines update those published in 2014, to reflect new developments. Further requirements such as the provision of extensively genotyped matched red cell units have also been addressed.
Tuesday May 14, 2024
Graham McIlroy Podcast - The management of newly diagnosed large B-cell lymphoma
Tuesday May 14, 2024
Tuesday May 14, 2024
Friday Apr 19, 2024
Diagnosis and management of heparin-induced thrombocytopenia: Third edition
Friday Apr 19, 2024
Friday Apr 19, 2024
A podcast recording by Dr Deepa J. Arachchillage on the guideline: Diagnosis and management of heparin-induced thrombocytopenia: Third edition.
Monday Apr 08, 2024
Diagnosis and management of marginal zone lymphomas
Monday Apr 08, 2024
Monday Apr 08, 2024
The objective of this podcast presented by Kim Linton and Renata Walewska is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with marginal zone lymphoma (MZL).
Thursday Apr 04, 2024
Guideline on the Investigation and management of a raised serum ferritin
Thursday Apr 04, 2024
Thursday Apr 04, 2024
Guideline on the Investigation and management of a raised serum ferritin: A podcast recording of a conversation between Dr Jenny Tam and Dr Wayne Thomas.
Wednesday Nov 29, 2023
Significant Haemoglobinopathies: a guideline for screening and diagnosis
Wednesday Nov 29, 2023
Wednesday Nov 29, 2023
Antenatal screening/testing of pregnant women should be carried out according to the guidelines of the National Health Service (NHS) Sickle Cell and Thalassaemia Screening Programme. Newborn screening and, when necessary, follow-up testing and referral, should be carried out according to the guidelines of the NHS Sickle Cell and Thalassaemia Screening Programme. All babies under 1 year of age arriving in the United Kingdom should be offered screening for sickle cell disease (SCD). Preoperative screening for SCD should be carried out in patients from ethnic groups in which there is a significant prevalence of the condition. Emergency screening with a sickle solubility test must always be followed by definitive analysis. Laboratories performing antenatal screening should utilise methods that are capable of detecting significant variants and are capable of quantitating haemoglobins A2 and F at the cut-off points required by the national antenatal screening programme. The laboratory must ensure a provisional report is available for antenatal patients within three working days from sample receipt.
Tuesday Nov 21, 2023
Diagnosis and management of Mantle Cell Lymphoma
Tuesday Nov 21, 2023
Tuesday Nov 21, 2023
The objective of this guideline is to provide healthcare professionals with clear guidance on the diagnosis and management of patients with mantle cell lymphoma.